Literature DB >> 11461197

Genetic polymorphism (G80A) of reduced folate carrier gene in ethnic populations.

P L Rady, S Szucs, R K Matalon, J Grady, S D Hudnall, L H Kellner, H Nitowsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11461197     DOI： 10.1006/mgme.2001.3197

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN： 1096-7192            Impact factor:   4.797


× No keyword cloud information.
  6 in total

1.  SLC19A1 pharmacogenomics summary.

Authors:  Sook Wah Yee; Li Gong; Ilaria Badagnani; Kathleen M Giacomini; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

2.  Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies.

Authors:  Ofer Spiegelstein; Amy Gould; Bogdan Wlodarczyk; Marlene Tsie; Xiufen Lu; Chris Le; Aron Troen; Jacob Selhub; Jorge A Piedrahita; J Michael Salbaum; Claudia Kappen; Stepan Melnyk; Jill James; Richard H Finnell
Journal:  Toxicol Appl Pharmacol       Date:  2005-02-15       Impact factor: 4.219

3.  Two siblings with a homozygous MTHFR C677T (G80A-RFC1) mutation and stroke.

Authors:  Massimo Barbagallo; Piero Pavone; Gemma Incorpora; Andrea Domenico Praticò; Olga Romantshik; Simonetta Friso; Alberto Spalice; Francesco Nicita; Agata Polizzi; Martino Ruggieri; Paola Iannetti
Journal:  Childs Nerv Syst       Date:  2008-10-29       Impact factor: 1.475

4.  An integrative computational approach for prioritization of genomic variants.

Authors:  Inna Dubchak; Sandhya Balasubramanian; Sheng Wang; Meydan Cem; Cem Meyden; Dinanath Sulakhe; Alexander Poliakov; Daniela Börnigen; Bingqing Xie; Andrew Taylor; Jianzhu Ma; Alex R Paciorkowski; Ghayda M Mirzaa; Paul Dave; Gady Agam; Jinbo Xu; Lihadh Al-Gazali; Christopher E Mason; M Elizabeth Ross; Natalia Maltsev; T Conrad Gilliam
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

Review 5.  The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.

Authors:  Shoshana Rudin; Marcus Marable; R Stephanie Huang
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-04-06       Impact factor: 7.691

6.  Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment.

Authors:  Nikola Kotur; Jelena Lazic; Bojan Ristivojevic; Biljana Stankovic; Vladimir Gasic; Lidija Dokmanovic; Nada Krstovski; Goran Milosevic; Dragana Janic; Branka Zukic; Sonja Pavlovic
Journal:  Genes (Basel)       Date:  2020-04-24       Impact factor: 4.096
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.